Farmaci anticoagulanti orali, società scientifiche preoccupate per la nota 101 di Aifa
(Adnkronos) - In una lettera Siset, Fcsa, Siapav, Simi, Fadoi, Sie, Sic, Anmco sottolineano che “il trattamento del tromboembolismo venoso è un problema clinico e gestionale molto complesso, per questo motivo la nota 101 istituita recentemente dall’Agenzia italiana del farmaco (Aifa) per definire i criteri di prescrivibilità a carico del Ssn dei farmaci anticoagulanti orali va rivista”.
Category
🗞
NewsTranscript
00:00 [MUSIC]
00:06 [FOREIGN]
00:16 >> [FOREIGN]
00:26 [FOREIGN]
00:36 [FOREIGN]
00:46 >> [FOREIGN]
00:56 >> [FOREIGN]
01:06 >> [FOREIGN]
01:16 >> [FOREIGN]
01:26 >> [FOREIGN]
01:36 >> [FOREIGN]
01:46 >> [FOREIGN]
01:56 >> [FOREIGN]
02:06 >> [FOREIGN]
02:16 >> [FOREIGN]
02:26 >> [FOREIGN]
02:36 >> [FOREIGN]
02:46 >> [FOREIGN]
02:56 >> [FOREIGN]
03:06 >> [FOREIGN]
03:16 >> [FOREIGN]
03:26 >> [FOREIGN]
03:36 >> [FOREIGN]
03:46 >> [FOREIGN]
03:56 >> [FOREIGN]
04:06 >> [FOREIGN]
04:16 [MUSIC]